Arkolith/Insider Trading/RAPP/Form 4

Ceesay Abraham

Chief Executive Officer, DirectorRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Oct 16, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$282K
Net Open-Market Flow
-$282K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2025Sell(S)1K$26.14$31K580K
Oct 15, 2025Sell(S)5K$25.72$120K581K
Oct 15, 2025Sell(S)4K$25.75$111K42K
Oct 15, 2025Sell(S)755$26.17$20K41K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-241472) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML